Health & Environmental Research Online (HERO)


Print Feedback Export to File
7045043 
Journal Article 
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy 
Pan, JJi; Guo, QJ; Kan, WaiK; Xiao, YouP; Wei, Xu; Quynh Thu Le; Glastonbury, CM; Colevas, AD; Weber, RS; Shah, JP; Lee, AWM; Ng, WaiT; Zong, JF; Chan, LLK; O'Sullivan, B; Lin, SJun; Sze, HCK; Chen, YunBin; Choi, HCW; , 
2016 
Yes 
Cancer
ISSN: 0008-543X
EISSN: 1097-0142 
WILEY 
HOBOKEN 
546-558 
26588425 
WOS:000369999600009 
BACKGROUNDAn accurate staging system is crucial for cancer management. Evaluations for continual suitability and improvement are needed as staging and treatment methods evolve.METHODSThis was a retrospective study of 1609 patients with nasopharyngeal carcinoma investigated by magnetic resonance imaging, staged with the 7th edition of the American Joint Committee on Cancer (AJCC)/International Union Against Cancer (UICC) staging system, and irradiated by intensity-modulated radiotherapy at 2 centers in Hong Kong and mainland China.RESULTSAmong the patients without other T3/T4 involvement, there were no significant differences in overall survival (OS) between medial pterygoid muscle (MP)lateral pterygoid muscle (LP), prevertebral muscle, and parapharyngeal space involvement. Patients with extensive soft tissue involvement beyond the aforementioned structures had poor OS similar to that of patients with intracranial extension and/or cranial nerve palsy. Only 2% of the patients had lymph nodes>6cm above the supraclavicular fossa (SCF), and their outcomes resembled the outcomes of those with low extension. Replacing SCF with the lower neck (extension below the caudal border of the cricoid cartilage) did not affect the hazard distinction between different N categories. With the proposed T and N categories, there were no significant differences in outcome between T4N0-2 and T1-4N3 disease.CONCLUSIONSAfter a review by AJCC/UICC preparatory committees, the changes recommended for the 8th edition include changing MP/LP involvement from T4 to T2, adding prevertebral muscle involvement as T2, replacing SCF with the lower neck and merging this with a maximum nodal diameter>6cm as N3, and merging T4 and N3 as stage IVA criteria. These changes will lead not only to a better distinction of hazards between adjacent stages/categories but also to optimal balance in clinical practicability and global applicability. Cancer 2016;122:546-558. (c) 2015 American Cancer Society.